bullish
Takeda + Shire - Highly Accretive Merger Considering Takeda’s Core Earnings
210 Views02 Apr 2018 21:47
Announcement – Takeda, on March 28, 2018, confirmed that it is officially considering making an offer for Shire (NASDAQ: SHPG) and that it has time...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 7-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Japan Pharmaceuticals: The Week that Was…13 Apr 2018
- Japan Pharma: Upcoming Catalysts & Event Driven Trading Ideas06 Apr 2018
- Japan Pharma - Drug Price Revision in April 201803 Apr 2018
- Takeda + Shire - Highly Accretive Merger Considering Takeda’s Core Earnings02 Apr 2018
- Japan Pharmaceutical - Sector Overview29 Mar 2018
- Takeda - Brigantinib Gets FDA Approval04 May 2017
x